SCHEMBL24758199

SCHEMBL24758199

CS(=O)(=O)c1cccc(NC(=O)c2c(C(F)(F)F)cnn2CC2CCCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
CREBBP Q92793 1/20 0.42
CARM1 Q86X55 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KLKB1 P03952 1/20 0.40
ALDH1A1 P00352 2/20 0.39
RXFP1 Q9HBX9 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SCN10A Q9Y5Y9 3/20 0.39
KIF18A Q8NI77 2/20 0.39
DHODH Q02127 1/20 0.39
ACKR3 P25106 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
CSNK2A1 P68400 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906371 0.99 AKR1C3 (0.47) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24906379 0.99 AKR1C3 (0.47) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24758197 0.98 AKR1C3 (0.47) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL30141424 0.92 AKR1C3 (0.45) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24758193 0.92 AKR1C3 (0.45) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24906460 0.91 AKR1C3 (0.45) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24757358 0.91 NR1H2 (0.41) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL30107048 0.91 NR1H2 (0.41) AKR1C3AKR1C2CREBBPCARM1MEN1
SCHEMBL24906272 0.90 MEN1 (0.52) AKR1C3AKR1C2MEN1KMT2ASCN10A
SCHEMBL24758196 0.90 AKR1C3 (0.41) AKR1C3AKR1C2CREBBPCARM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355733-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2024-04-24 EP claimed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO claimed
EP-4355733-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2024-04-24 EP disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A AKR1C3 1950/4885AKR1C2 1995/4885CREBBP 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.